Lexicon Pharmaceuticals reported 22.98M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8383M 448M
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Acorda Therapeutics ACOR:US $ 54.46M 6.99M
Agios Pharmaceuticals AGIO:US $ 89.16M 66K
Akebia Therapeutics AKBA:US $ 103.64M 28.61M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Arena Pharmaceuticals ARNA:US $ 194.48M 50.09M
AstraZeneca AZN:LN 11.54B 4.45B
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Clovis Oncology CLVS:US $ 95.38M 978K
Coherus Biosciences CHRS:US $ 115.29M 3.48M
Dicerna Pharmaceuticals DRNA:US $ 83.23M 1.64M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Esperion Therapeutics ESPR:US $ 70.15M 3.04M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Illumina ILMN:US $ 1.65B 714M
Insmed INSM:US $ 150.37M 1.25M
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
Ironwood Pharmaceuticals IRWD:US $ 38.58M 0.36M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Lexicon Pharmaceuticals LXRX:US 22.98M 4.79M
Macrogenics MGNX:US $ 68.65M 2.39M
Mannkind MNKD:US $ 23.87M 31.81M
Merk MRK:US $ 8328M 1460M
Moderna Inc MRNA:US 1.41B 119M
Novartis NOVN:VX 10.13B 319M
Ptc Therapeutics PTCT:US $ 231.82M 16.65M
Puma Biotechnology PBYI:US $ 87.84M 32.73M
Regulus Therapeutics RGLS:US $ 8.42M 1.78M
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Thermo Fisher Scientific TMO:US $ 7052M 58M
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
United Therapeutics UTHR:US $ 216M 10.6M
Vanda Pharmaceuticals VNDA:US $ 59.28M 3.75M